(NEUE) NeueHealth - Ratings and Ratios

NeueHealth, Inc. (NYSE: NEUE) operates as a healthcare services provider in the United States, focusing on value-based care delivery and population health management. The company functions through two primary segments: NeueCare and NeueSolutions. The NeueCare segment provides direct patient care services through a network of owned and affiliated clinics, including risk-bearing arrangements under brands such as Centrum Health, AssociatesMD, and Premier Medical Associates. These services are delivered to patients enrolled in ACA marketplace plans, Medicare, and Medicaid programs. Additionally, NeueCare offers integrated care solutions, including embedded pharmacies, laboratory services, radiology, and population health-focused specialty care. It also provides chronic care management, transitions of care, and referral management services to improve patient outcomes and reduce healthcare costs.

The NeueSolutions segment supports healthcare providers and medical groups in navigating performance-based payment arrangements. This includes participation in programs aimed at expanding access to healthcare for Medicare beneficiaries. Formerly known as Bright Health Group, Inc., the company rebranded as NeueHealth, Inc. in January 2024 to reflect its strategic shift toward integrated, value-based healthcare delivery. Incorporated in 2015 and headquartered in Doral, Florida, NeueHealth aims to align incentives across payors, providers, and patients to enhance care quality and affordability. Web URL: https://www.neuehealth.com.

Based on and , NeueHealths stock (NEUE) is trading at $7.25 with a 20-day average volume of 14,368 shares. The stocks short-term technical outlook is neutral, with the 20-day SMA ($7.32) slightly above the current price, while the 50-day SMA ($7.15) indicates potential support. The ATR of 0.11 suggests low volatility. On the fundamental side, the companys market cap of $60.74M and a P/E ratio of 1.80 signal undervaluation relative to earnings. The RoE of 84.03% highlights strong profitability compared to equity. Over the next 3 months, expect NEUE to trade in a narrow range between $7.00 and $7.50, with potential upside driven by improving fundamentals and execution on value-based care initiatives.